-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III

Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Lai N. Chan, PhD1, Christian Hurtz, PhD2, Mark E. Robinson, PhD1*, Etienne Leveille, MD1, Huimin Geng, PhD3, Rebecca Caeser, PhD4*, Liang Xu, PhD5*, Kohei Kume, PhD6*, Gang Xiao, PhD5* and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT
2Lewis Katz School of Medicine, Temple University, Philadelphia, PA
3Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5College of Life Sciences, Zhejiang University, Hangzhou, China
6Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, Duarte, CA

Jan Zuna1, Lenka Hovorkova1*, Justina Krotka1*, Amelie Koehrmann2*, Michela Bardini3*, Lucie Winkowska1*, Eva Fronkova1*, Julia Alten2*, Rolf Koehler4*, Cornelia Eckert, PhD5*, Lisa Brizzolara3*, Jan Stuchly1*, Martin Zimmermann, PhD6*, Paola De Lorenzo7*, Maria Grazia Valsecchi, PhD7*, Valentino Conter, MD8*, Jan Stary, MD9*, Martin Schrappe, MD10, Andrea Biondi, MD8, Jan Trka1, Marketa Zaliova11, Giovanni Cazzaniga, PhD3,12* and Gunnar Cario2*

1CLIP, Dept. of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
2Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany, Kiel, Germany
3Tettamanti Research Center, Pediatrics, University of Milano-Bicocca / Fondazione Tettamanti, Monza, Italy
4Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany
5Charité-Universitätsmedizin Berlin, Berlin, Germany
6Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany
7EsPhALL Trial Data Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
8Pediatric Hemato-Oncolgy, Fondazione MBBM/ASST-Monza, University of Milano-Bicocca, Monza, Italy
9Dept. of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
10University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
11CLIP - Childhood Leukemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
12Medical Genetics, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

Hayden L Bell, PhD1*, Mankaran Singh, MSc2*, Helen J Blair, PhD2*, Olaf Heidenreich, PhD3*, Frederik W. van Delft, MD, PhD2*, Anthony V. Moorman4, John Lunec, PhD MRCR(Hon) FRCPath5* and Julie Irving, PhD2

1Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle-upon-Tyne, United Kingdom
2Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom
3Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
4Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle, United Kingdom
5Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom

Margot S.F. Roeten1,2*, Johan van Meerloo1,2*, Zinia Kwidama1,2*, Gaye Jenkins3*, Suzanne N. van Dijk1,2*, David T. Teachey, MD4, Meenakshi Devidas, PhD, MBA5, Mignon L. Loh, MD6, Gertjan J.L. Kaspers, Prof. MD, PhD7,8, Sonja Zweegman, MD, PhD1,9, Gerrit Jansen, PhD2,10*, Jacqueline Cloos, Prof1,2* and Terzah M. Horton, MD, PhD3

1Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
3Department of Pediatrics Baylor College of Medicine, Texas Children's Hospital, Houston, TX
4Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Rutledge, PA
5Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN
6Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California Benioff Children’s Hospital, Seattle, WA
7Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
8Pediatric Oncology, Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
9Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands
10Amsterdam Rheumatology and Immunology Center, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Zeljko Antic1*, Alena van Bömmel, PhD2*, Konstantin Riege, PhD2*, Jana Lentes, MSc1*, Charlotte Schröder, BSc1*, Julia Alten3*, Lara Fuhrmann, MD1*, Martin Zimmermann, PhD4*, Cornelia Eckert, PhD5*, Gunnar Cario, MD, PhD3*, Martin Schrappe, MD3, Brigitte Schlegelberger, MD1, Steve Hoffmann, MD, PhD6* and Anke K. Bergmann, MD1*

1Department of Human Genetics, Hannover Medical School (MHH), Hannover, Germany
2Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany
3Department of Pediatrics, Berlin-Frankfurt-Münster ALL Study Group Germany (BFM-G), University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
4Department of Pediatric Hematology and Oncology, Hannover Medical School (MHH), Hannover, Germany
5Department of Pediatric Oncology and Hematology, Charité University Medical Center, Berlin, Germany
6Leibniz Institute on Ageing-Fritz Lipmann Institute (FLI), Jena, Germany

Yuta Katai1*, Tatsuya Kamitori2*, Hiroo Ueno3*, Ryo Akazawa2*, Kiyotaka Isobe2*, Itaru Kato2*, Toshihiko Imamura4, Katsuyoshi Koh5*, Satoshi Saida2* and Junko Takita2*

1Faculty of Medicine, Kyoto University, Kyoto-Shi, Japan
2Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Department of Pediatrics, Kyoto Katsura Hospital, Kyoto, Japan
4Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan
5Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan

Louise Ahlgren, PhD1*, Mattias Pilheden, PhD1*, Helena Sturesson, PhD1*, Varsha Singh, PhD1*, Qirui Zhang, PhD1*, Anders Castor, MD, PhD2*, Cornelis Jan Pronk, MD, PhD2*, Gisela Barbany, MD, PhD3*, Katja Pokrovskaja Tamm, PhD4*, Linda Fogelstrand, MD PhD5, Michael P Walsh, PhD6*, Guangchun Song6*, Jinghui Zhang, PhD7*, Jing Ma, PhD6* and Anna Hagstroem-Andersson, PhD1,8

1Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
2Childhood Cancer Center, Skane University Hospital, Lund, SWE
3Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden
4Department of Oncology and Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
5Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
6Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
7Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN
8Center for Translational Genomics, Lund University, Lund, Sweden

Katarzyna Szoltysek, PhD1,2*, Rachel L. Cameron2,3*, Anja Krippner-Heidenreich, PhD2*, Milad Rasouli2*, Jayne Y. Hehir-Kwa, PhD2*, Elizabeth K. Schweighart2*, Minoo Ashtiani2*, Janine Stutterheim, MD, PhD2, Josef Vormoor, Prof, MD, PhD2,3,4 and Olaf Heidenreich, PhD2,3*

1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland
2Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
3Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, United Kingdom
4University Medical Center Utrecht, Utrecht, Netherlands

Caroline R. M. Wiggers, PhD1,2, Eugene Y. Cho1*, Justin Hegel1*, Julia Frede, PhD, MPhil2,3, Hannah Stuart3*, Klothilda K. Lim3*, Yana Pikman, MD4,5, Marian H. Harris, MD, PhD6*, Andrew E. Place, MD, PhD1,7,8, Lewis B. Silverman, MD7,9, Jens G. Lohr, MD, PhD2,3,10 and Birgit Knoechel, MD, PhD1,2,10,11

1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
2Harvard Medical School, Boston, MA
3Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
4Dana Farber Cancer Institute, Boston, MA
5Boston Children’s Hospital, Boston, MA
6Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA
7Department of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, MA
8Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
9Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
10Broad Institute of MIT and Harvard, Cambridge, MA
11Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA

Joshua Anil, BSc1, Andrew Lytle, MD, PhD2*, Ahab Alnemri, BA1*, Brian Lockhart3* and Vinodh Pillai, MD3,4

1University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
2Centre for Lymphoid Cancer, Department of Pathology, BC Cancer, Vancouver, BC, Canada
3Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Noam E. Kopmar, MD1,2, Xiaoyu Qu, Ph.D.2*, Yajuan J. Liu, PhD3*, Ted A. Gooley, Ph.D.2*, Lucas Zarling, MD1*, Mary-Elizabeth M. Percival, MD1,2, Cristina Ghiuzeli, MD1,2, Min Fang, MD, PhD2,3 and Ryan D. Cassaday, MD1,4

1Department of Medicine, University of Washington, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA
4UW/FHCRC, Seattle, WA

Qian Wang1*, Haiping Dai1*, Wenzhi CAI, MD1*, Qinrong Wang1*, Zhu Mingqing1*, Lingzhi Yan, MD, PhD1*, Yan Yu1*, Hongjie Shen, MD, PhD1*, Yang Xu, MD, PhD2*, Ying Wang1*, Miao Miao, MD1*, Shengli Xue1*, Yue Han1*, Xiaowen Tang, MD, PhD1*, Huiying Qiu1*, Aining Sun1*, Jinyan Huang3,4*, Depei Wu1 and Suning Chen, MD, PhD1*

1Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China
2National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China
3Biomedical big data center, Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Zhejiang University Cancer Center, Zhejiang University, Hangzhou, China

Peter M. Gordon, MD, PhD1, Jason Ostergaard, BA2*, Leslie M. Jonart, MS1*, M Frank Erasmus, PhD3*, Bridget S. Wilson, PhD4 and Stuart S. Winter, MD5

1Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, MN
2Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, MN
3Specifica, Inc., Santa Fe, NM
4Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM
5Research Institute and Cancer and Blood Disorders Program, Children's Minnesota, Eagan, MN

Danielle Brandes1,2*, Triantafyllia Brozou, MD2*, Karin Nebral, PhD3,4*, Anke K. Bergmann, MD5*, Oskar A. Haas, MD3,4,6, Stefan Köhrer, MD3,4*, Martin Stanulla, MD, MSc7*, Ute Fischer, PhD2,8*, Arndt Borkhardt, MD2,8 and Rabea Wagener, PhD2,8*

1Duesseldorf School of Oncology (DSO), Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany
2Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University and University Hospital Duesseldorf, Duesseldorf, Germany
3St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria
4Labdia Labordiagnostik GmbH, Clinical Genetics, Vienna, Austria
5Institute of Human Genetics, Hannover Medical School (MHH), Hanover, Germany
6St. Anna Children's Hospital, Department of Pediatric Hematology/Oncology, Pediatric Clinic, Medical University, Vienna, Austria
7Pediatric Hematology and Oncology, Hannover Medical School (MHH), Hanover, Germany
8German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany

Cai Zihong*, Bingqing Tang*, Xiuli Xu*, Zicong Huang*, Qifa Liu and Hongsheng Zhou*

Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Hiroyuki Kimura, M.D.1*, Masahiro Onozawa, M.D., Ph.D.1, Shota Yoshida, MD1*, Naoki Miyashita, M.D.1*, Shogo Takahashi, M.D.1*, Shota Yokoyama2*, Toshihiro Matsukawa, M.D., Ph.D.2*, Shinsuke Hirabayashi, M.D.3,4*, Shinichi Fujisawa5*, Shuichi Ota, M.D., Ph.D.6, Daisuke Hidaka, M.D., Ph.D.6*, Akio Mori, MD, PhD7, Takeshi Kondo8, Yasutaka Kakinoki, M.D., Ph.D.9*, Yutaka Tsutsumi, M.D., Ph.D.10*, Satoshi Yamamoto, M.D., Ph.D.11*, Takuto Miyagishima, M.D., Ph.D.12*, Takahiro Nagashima, M.D., Ph.D.13*, Makoto Ibata, M.D., Ph.D.14*, Hajime Kobayashi, M.D, Ph.D.15*, Yoshihito Haseyama, M.D, Ph.D.16*, Katsuya Fujimoto, M.D., Ph.D.17*, Toshimichi Ishihara, M.D., Ph.D.18*, Hajime Sakai, M.D, Ph.D.19 and Takanori Teshima, M.D., Ph.D.1,20

1Department of Hematology, Hokkaido University Faculty of Medicine, Graduate school of Medicine, Sapporo, Japan
2Department of Hematology, Hokkaido University Hospital, Sapporo, Japan, Sapporo, Japan
3Hokkaido University Hospital, Sapporo, Japan
4Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
5Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
6Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
7Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
8Aiiku Hospital, Sapporo, Japan
9Department of Hematology, Asahikawa City Hospital, Asahikawa, HOK, Japan
10Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan
11Department of Hematology, Sapporo City General Hospital, Sapporo, Japan
12Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan
13Department of Internal Medicine, Kitami Red Cross Hospital, Kitami, Japan
14Department of Hematology, Sapporo-Kosei General Hospital, Sapporo, Japan
15Department of Hematology, Obihiro Kosei Hospital, Obhiro, Japan
16Department of Hematology, Tonan Hospital, Sapporo, Japan
17Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan
18Department of Hematology, Kin-ikyo Chuo Hospital, Sapporo, Japan
19Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan
20Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan

Noemi Di Marzo, PhD Student1*, Francesca Pischiutta, PhD2*, Rosaria Pascente2*, Nicolò Panini3*, Erica Dander, PhD4*, Alessandra Fallati, PhD Student5*, Elisa Zanier, MD2*, Giovanna D'Amico, BSc, PhD, MSc5* and Andrea Biondi, MD5,6,7,8,9,10,11,12

1Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy
2Dipartimento Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
3IRCCS Istituto Di Ricerche Farmacologiche Mario Negri, Milano, Italy
4Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Idaho, Italy
5Tettamanti Research Center, Department of Pediatrics, University of Milano - Bicocca/Fondazione MBBM, Monza, Italy
6Laboratorio di Terapia Cellulare e Genica Stefano Verri, ASST-Monza, Ospedale San Gerardo, Monza, Italy
7Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, MI, Italy
8University of North Carolina, Chapel Hill, NC
9Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza, Italy
10AIEOP - Associazione Italiana Ematologia Oncologia Pediatrica, Monza, Italy
11Clinica Pediatrica Università Milano - Bicocca/Fondazione MBBM, Monza, Italy
12Pediatric Bone Marrow Transplant Unit, Fondazione MBBM -Milano Bicocca University, Monza, Italy

*signifies non-member of ASH